CellRapeutics™ Leukopak from Arrhythmia Donor (XS-0426-XU272)

Name: CellRapeutics™ Leukopak from Arrhythmia Donor
SKU: XS-0426-XU272
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This Leukopak is derived from donors with documented cardiac arrhythmias. While primarily a rhythmic disorder, this collection captures the systemic inflammatory milieu and oxidative stress markers often associated with atrial remodeling. It is designed for researchers studying the role of circulating monocytes and specific cytokine patterns in the pathogenesis of cardiac conduction abnormalities and the associated thromboembolic risks.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Arrhythmia Donor

Cat. No.
XS-0426-XU272

Donor Age
Middle-Aged, Senior

Donor Health
Donors present with chronic cardiac conduction disorders. The leukocyte profile reflects underlying cardiac hemodynamic stress and potential signatures of myocardial remodeling or localized inflammatory triggers.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose, standard formulation ensuring electrolyte stability to protect donor and cell viability.

Additional Donor Information
Each lot features a Leukopak from donors with clinically diagnosed arrhythmias. Profiles include cardiac history and current anti-arrhythmic or anticoagulant medication, supporting research into inflammatory triggers of cardiac conduction disturbances.

Clinical Profile
Specific arrhythmia type, classification, and history of ablation or anti-arrhythmic medication.

Additional Information

Medication History
Available upon request. Includes records of anti-arrhythmic drugs, anticoagulants, and medications for underlying structural heart disease.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Arrhythmia Donor, Leukopak, Arrhythmia

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Arrhythmia Donor (XS-0426-XU272). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.